Cardiology

Angiotensin receptor blockers reduce no-reflow post-PCI

(HealthDay) -- For patients with acute myocardial infarction (AMI), pretreatment with angiotensin receptor blockers (ARBs) is linked with reduced incidence of the no-reflow phenomenon after percutaneous coronary intervention ...

Diseases, Conditions, Syndromes

Role of screening, monitoring in early kidney disease unclear

(HealthDay) -- At least one in 10 U.S. adults is estimated to have chronic kidney disease, but whether screening and monitoring people in the earlier stages of the disease provides a benefit just isn't clear, a new review ...

Neuroscience

Keeping one's eyes on the goal -- despite stress

Stressed people fall into habits and their behaviour is not goal-directed. That the neurotransmitter norepinephrine plays a decisive role here is now reported in the Journal of Neuroscience by scientists from Bochum led by ...

Medical research

New bitter blocker discovered

Although bitterness can sometimes be desirable – such as in the taste of coffee or chocolate – more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. ...

page 11 from 12